A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops ulcers).
Epistemonikos ID: 940c9bc78356ecabc52ee4fce22cf5dcb16ea5bd
First added on: May 12, 2026